What is myTomorrows?
myTomorrows operates at the intersection of patient advocacy and pharmaceutical innovation, facilitating access to clinical trials and expanded access programs. The company provides crucial patient-centric solutions and real-world data services, enhancing the discovery and utilization of treatments for serious diseases. By serving patients, healthcare professionals, and BioPharma entities, myTomorrows empowers individuals by broadening their access to comprehensive therapeutic pathways.
How much funding has myTomorrows raised?
myTomorrows has raised a total of $47.3M across 4 funding rounds:
Angel/Seed
$2.2M
Unspecified
$5.6M
Private Equity
$10.5M
Private Equity
$29M
Angel/Seed (2014): $2.2M, investors not publicly disclosed
Unspecified (2014): $5.6M led by Sofinnova Ventures and Balderton Capital LLP
Private Equity (2017): $10.5M supported by Balderton Capital LLP, Sofinnova Partners, EQT Ventures, and Octopus Ventures
Private Equity (2025): $29M featuring Avego
Key Investors in myTomorrows
Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. They are a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage.
Balderton Capital LLP
Balderton Capital is a London-based venture capital firm that invests in early-stage, high-growth technology companies across Europe, typically leading Seed and Series A rounds.
Octopus Ventures
Octopus Investments is a UK-based provider of specialist tax-efficient investments, focusing on VCTs and inheritance tax solutions, catering to individual investors, financial advisers, and institutional clients.
What's next for myTomorrows?
The recent major strategic investment signals a new phase of growth and expansion for myTomorrows. This capital infusion is expected to accelerate the company's mission to improve treatment accessibility and streamline clinical trial recruitment and expanded access management. With a focus on patient empowerment and data-driven insights, myTomorrows is well-positioned to deepen its impact within the life sciences sector, potentially driving further innovation in patient care and pharmaceutical development.
See full myTomorrows company page
